Therapeutic Merit of Solifenacin in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms

NCT01381120 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
84
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Barrie Urology Associates

Collaborators